These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7844519)

  • 1. Brefeldin A inhibits vaccinia virus envelopment but does not prevent normal processing and localization of the putative envelopment receptor P37.
    Ulaeto D; Grosenbach D; Hruby DE
    J Gen Virol; 1995 Jan; 76 ( Pt 1)():103-11. PubMed ID: 7844519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Movements of vaccinia virus intracellular enveloped virions with GFP tagged to the F13L envelope protein.
    Geada MM; Galindo I; Lorenzo MM; Perdiguero B; Blasco R
    J Gen Virol; 2001 Nov; 82(Pt 11):2747-2760. PubMed ID: 11602786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of a vaccinia virus mutant expressing a nonpalmitylated form of p37, a mediator of virion envelopment.
    Grosenbach DW; Hruby DE
    J Virol; 1998 Jun; 72(6):5108-20. PubMed ID: 9573282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccinia virus p37 interacts with host proteins associated with LE-derived transport vesicle biogenesis.
    Chen Y; Honeychurch KM; Yang G; Byrd CM; Harver C; Hruby DE; Jordan R
    Virol J; 2009 Apr; 6():44. PubMed ID: 19400954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementation of P37 (F13L gene) knock-out in vaccinia virus by a cell line expressing the gene constitutively.
    Borrego B; Lorenzo MM; Blasco R
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():425-432. PubMed ID: 10073703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human cytomegalovirus maturation by brefeldin A.
    Eggers M; Bogner E; Agricola B; Kern HF; Radsak K
    J Gen Virol; 1992 Oct; 73 ( Pt 10)():2679-92. PubMed ID: 1328480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence and analysis of a swinepox virus homologue of the vaccinia virus major envelope protein P37 (F13L).
    Bárcena J; Lorenzo MM; Sánchez-Puig JM; Blasco R
    J Gen Virol; 2000 Apr; 81(Pt 4):1073-85. PubMed ID: 10725435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palmitylation of the vaccinia virus 37-kDa major envelope antigen. Identification of a conserved acceptor motif and biological relevance.
    Grosenbach DW; Ulaeto DO; Hruby DE
    J Biol Chem; 1997 Jan; 272(3):1956-64. PubMed ID: 8999886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progeny vaccinia and human cytomegalovirus particles utilize early endosomal cisternae for their envelopes.
    Tooze J; Hollinshead M; Reis B; Radsak K; Kern H
    Eur J Cell Biol; 1993 Feb; 60(1):163-78. PubMed ID: 8385018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Envelope formation is blocked by mutation of a sequence related to the HKD phospholipid metabolism motif in the vaccinia virus F13L protein.
    Roper RL; Moss B
    J Virol; 1999 Feb; 73(2):1108-17. PubMed ID: 9882312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of extracellular particles by recombinant vaccinia virus over-expressing the major envelope protein p37K.
    Schmutz C; Wittek R
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():2963-8. PubMed ID: 8847501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of receptor-mediated endocytosis in the formation of vaccinia virus extracellular enveloped particles.
    Husain M; Moss B
    J Virol; 2005 Apr; 79(7):4080-9. PubMed ID: 15767409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the vaccinia virus L1R myristylprotein as a component of the intracellular virion envelope.
    Ravanello MP; Hruby DE
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1479-83. PubMed ID: 8207414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of inhibitors of the intracellular exocytic pathway on glycoprotein processing and maturation of Junin virus.
    Candurra NA; Damonte EB
    Arch Virol; 1997; 142(11):2179-93. PubMed ID: 9672585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific targeting of the F13L protein by ST-246 affects orthopoxvirus production differently.
    Duraffour S; Vigne S; Vermeire K; Garcel A; Vanstreels E; Daelemans D; Yang G; Jordan R; Hruby DE; Crance JM; Garin D; Andrei G; Snoeck R
    Antivir Ther; 2008; 13(8):977-90. PubMed ID: 19195323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the site occupancy constraints of primary amino acid sequences in the motif directing palmitylation of the vaccinia virus 37-kDa envelope protein.
    Hansen SG; Grosenbach DW; Hruby DE
    Virology; 1999 Feb; 254(1):124-37. PubMed ID: 9927580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particles.
    Sanderson CM; Hollinshead M; Smith GL
    J Gen Virol; 2000 Jan; 81(Pt 1):47-58. PubMed ID: 10640541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical analysis of the major vaccinia virus envelope antigen.
    Schmutz C; Rindisbacher L; Galmiche MC; Wittek R
    Virology; 1995 Oct; 213(1):19-27. PubMed ID: 7483262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brefeldin A and monensin arrest cell surface expression of membrane glycoproteins and release of rubella virus.
    Qiu Z; Tufaro F; Gillam S
    J Gen Virol; 1995 Apr; 76 ( Pt 4)():855-63. PubMed ID: 9049331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence.
    Engelstad M; Smith GL
    Virology; 1993 Jun; 194(2):627-37. PubMed ID: 8503178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.